Castle Biosciences
CSTL
CSTL
126 hedge funds and large institutions have $443M invested in Castle Biosciences in 2020 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 51 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
42% more funds holding
Funds holding: 89 → 126 (+37)
17.73% more ownership
Funds ownership: 42.94% → 60.68% (+18%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $339K
Holders
126
Holding in Top 10
2
Calls
–
Puts
$339K
Top Buyers
| 1 | +$16.6M | |
| 2 | +$12.1M | |
| 3 | +$11.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.4M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$11.2M |
Top Sellers
| 1 | -$3.31M | |
| 2 | -$2.4M | |
| 3 | -$882K | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$874K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$833K |